SecSonar.com

Schrödinger, Inc. (SDGR)

Schrödinger, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Schrödinger, Inc. (SDGR) is a Medical - Healthcare Information Services company based in US with a market capitalization of $1.1B. Revenue grew 23.3% year-over-year and the company generated $12.5M in free cash flow. This page tracks SDGR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 891 employees · IPO Feb 6, 2020

Valuation

Valuation & price

$11.95 · as of May 17, 2026 · -48.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.14

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$23.03$17.05$11.08Jul 25Dec 25Jul 26Jul 7, 25$20.63Jul 9, 25$21.69Jul 11, 25$21.01Jul 15, 25$20.37Jul 17, 25$21.65Jul 21, 25$22.82Jul 23, 25$23.03Jul 25, 25$22.23Jul 29, 25$21.17Jul 31, 25$20.33Aug 4, 25$19.99Aug 6, 25$19.34Aug 11, 25$18.63Aug 13, 25$19.84Aug 15, 25$19.38Aug 19, 25$19.40Aug 21, 25$19.58Aug 25, 25$19.54Aug 27, 25$19.79Aug 29, 25$19.51Sep 3, 25$19.29Sep 5, 25$19.13Sep 9, 25$19.46Sep 11, 25$18.78Sep 16, 25$19.11Sep 18, 25$19.65Sep 22, 25$19.72Sep 24, 25$19.06Sep 26, 25$19.30Sep 30, 25$20.06Oct 2, 25$21.45Oct 6, 25$21.29Oct 8, 25$20.72Oct 10, 25$19.08Oct 14, 25$19.43Oct 16, 25$20.31Oct 21, 25$20.87Oct 23, 25$21.96Oct 27, 25$22.17Oct 29, 25$21.15Oct 31, 25$21.04Nov 4, 25$19.99Nov 6, 25$18.65Nov 10, 25$18.29Nov 12, 25$17.98Nov 14, 25$17.64Nov 18, 25$17.01Nov 20, 25$16.33Nov 25, 25$17.45Nov 28, 25$17.56Dec 2, 25$17.08Dec 4, 25$18.42Dec 8, 25$17.76Dec 10, 25$17.94Dec 12, 25$18.05Dec 16, 25$17.94Dec 18, 25$17.20Dec 22, 25$19.39Dec 24, 25$18.38Dec 29, 25$17.84Jan 2, 26$17.98Jan 6, 26$18.79Jan 8, 26$18.61Jan 12, 26$18.64Jan 14, 26$18.33Jan 16, 26$16.79Jan 21, 26$16.42Jan 23, 26$16.42Jan 27, 26$14.88Jan 29, 26$14.32Feb 2, 26$14.09Feb 4, 26$13.36Feb 9, 26$13.60Feb 11, 26$11.98Feb 13, 26$11.40Feb 18, 26$11.81Feb 20, 26$11.53Feb 24, 26$11.30Feb 26, 26$12.76Mar 2, 26$12.15Mar 4, 26$13.12Mar 6, 26$12.74Mar 10, 26$12.63Mar 12, 26$12.16Mar 17, 26$12.29Mar 19, 26$12.20Mar 23, 26$11.87Mar 25, 26$11.40Mar 27, 26$11.08Mar 31, 26$11.36Apr 2, 26$11.58Apr 7, 26$11.39Apr 9, 26$11.47Apr 13, 26$11.45Apr 15, 26$12.40Apr 17, 26$12.34Apr 22, 26$12.35Apr 24, 26$11.79Apr 28, 26$12.24Apr 30, 26$11.96May 4, 26$12.90May 6, 26$12.98May 8, 26$13.13May 12, 26$12.69May 14, 26$12.62May 18, 26$12.05May 20, 26$12.32May 22, 26$13.30May 28, 26$14.16Jun 1, 26$15.80Jun 3, 26$14.93Jun 5, 26$14.38Jun 9, 26$14.52Jun 11, 26$14.60Jun 15, 26$14.60Jun 17, 26$15.53Jun 22, 26$15.23Jun 24, 26$15.33Jun 26, 26$16.86Jul 2, 26$16.88
$11.0752-week range$23.03
Loading valuation history…

Fundamentals

Key fundamentals

$1.1B

Market cap

23.3%

Revenue growth (YoY)

55.7%

Gross margin

$12.5M

Free cash flow (USD)

-$286.2M

Net debt

Net cash position

1.1%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$55.7MFY 2018$66.6MFY 2019$85.5MFY 2020$108.1MFY 2021$137.9MFY 2022$181.0MFY 2023$216.7MFY 2024$207.5MFY 2025$255.9M
$55.7M$255.9M

Free cash flow by year

2017 → 2025

FY 2017$-19.0MFY 2018$-29.0MFY 2019$-27.9MFY 2020$14.2MFY 2021$-77.8MFY 2022$-127.7MFY 2023$-150.1MFY 2024$-164.7MFY 2025$12.5M
-$19M$12.5M

Gross margin by year

2021 → 2025

FY 202147.6%FY 202255.8%FY 202364.9%FY 202463.6%FY 202555.7%
47.6%55.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCash Payment ReceivedJun 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 23, 2026Filing
  • 8-K eventExecutive Separation AgreementJun 8, 2026Filing
  • 8-K eventExecutive DepartureMay 20, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing
  • Insider sellInsider Sell $11K · 10b5-1 PlanJain Rachit · EVP & CFO · $10.8KApr 17, 2026Filing
  • Insider sellInsider Sell $1.1M · 10b5-1 PlanFarid Ramy · Director, President & CEO · $1.1MApr 17, 2026Filing

Questions

Frequently asked questions

What is Schrödinger, Inc.'s market cap?

Schrödinger, Inc. (SDGR) has a market capitalization of $1.1B.

What is SDGR's P/E ratio?

A meaningful P/E ratio is not available for SDGR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SDGR's price-to-book (P/B) ratio?

SDGR trades at 3.14 times book value per share.

Are insiders buying SDGR stock?

SEC Form 4 filings show no open-market insider buys at Schrödinger, Inc. in the last 90 days (2 sells).

Same arena

Related companies in Medical - Healthcare Information Services

OMDA

Omada Health

$1.1B

GDRX

GoodRx Holdings, Inc.

$1B

CERT

Certara, Inc.

$925.6M

TDOC

Teladoc Health, Inc.

$1.4B

NUTX

Nutex Health, Inc.

$792.1M

WGS

GeneDx Holdings Corp.

$1.5B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.